These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2492412)

  • 1. 1,25(OH)2-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages.
    Crowle AJ; Salfinger M; May MH
    Am Rev Respir Dis; 1989 Feb; 139(2):549-52. PubMed ID: 2492412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3.
    Crowle AJ; May MH
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2217-22. PubMed ID: 2127346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages.
    Crowle AJ; Sbarbaro JA; May MH
    Am Rev Respir Dis; 1986 Nov; 134(5):1052-5. PubMed ID: 3535593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative abilities of various metabolites of vitamin D to protect cultured human macrophages against tubercle bacilli.
    Crowle AJ; Ross EJ
    J Leukoc Biol; 1990 Jun; 47(6):545-50. PubMed ID: 2161895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.
    Salfinger M; Crowle AJ; Reller LB
    J Infect Dis; 1990 Jul; 162(1):201-7. PubMed ID: 2113074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
    Heifets L; Higgins M; Simon B
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
    Zhang J; Guo M; Huang ZX; Bao R; Yu Q; Dai M; Wang X; Rao Y
    Chin Med J (Engl); 2019 Sep; 132(17):2089-2095. PubMed ID: 31425356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
    Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
    BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of rifampin and pyrazinamide within the human macrophage.
    Sbarbaro JA; Iseman MD; Crowle AJ
    Am Rev Respir Dis; 1992 Dec; 146(6):1448-51. PubMed ID: 1456560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of pyrazinamide and ofloxacin within the human macrophage.
    Sbarbaro JA; Iseman MD; Crowle AJ
    Tuber Lung Dis; 1996 Dec; 77(6):491-5. PubMed ID: 9039440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ethambutol on tubercle bacilli within cultured human macrophages.
    Crowle AJ; Sbarbaro JA; Judson FN; May MH
    Am Rev Respir Dis; 1985 Oct; 132(4):742-5. PubMed ID: 3931521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
    Hu Y; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is pyrazinamide bactericidal against Mycobacterium tuberculosis?
    Heifets LB; Lindholm-Levy PJ
    Am Rev Respir Dis; 1990 Jan; 141(1):250-2. PubMed ID: 2105072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
    Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages.
    Crowle AJ; Ross EJ
    Infect Immun; 1989 Mar; 57(3):840-4. PubMed ID: 2492972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages.
    Crowle AJ; Ross EJ; May MH
    Infect Immun; 1987 Dec; 55(12):2945-50. PubMed ID: 3119492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
    Njire M; Tan Y; Mugweru J; Wang C; Guo J; Yew W; Tan S; Zhang T
    Adv Med Sci; 2016 Mar; 61(1):63-71. PubMed ID: 26521205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages.
    Crowle AJ; Sbarbaro JA; May MH
    Tubercle; 1988 Mar; 69(1):15-25. PubMed ID: 3140456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.